Skip to main content

Drug Maker Aryx to Use GenomeQuest's Sequence IP Search Service

NEW YORK (GenomeWeb News) — Aryx Therapeutics will use GenomeQuest’s sequence search service for use in intellectual property research related to its retrometabolic drug studies, GenomeQuest said today.
 
GenomeQuest’s software is used by researchers and IP lawyers to evaluate the patentability and competitive landscape for gene sequences.
 
Jeff Anderson, Aryx Therapeutics’ senior manager of IP, said his company looked to GenomeQuest to simplify the process of understanding the patent landscape that surrounds its IP interests in retrometabolic drug design.
  
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.